Reported side effects are typically mild and transient: BPC-157: Nausea (rare), mild fatigue in the first week, minor injection site redness TB-500: Mild lethargy during the loading phase, transient head rush immediately after injection, injection site discomfort Combined stack: No documented synergistic toxicity in preclinical or clinical observational data The more significant risks relate to sourcing and administration rather than the peptides themselves
Some individuals might experience mild discomfort at the injection site, a bit of nausea, or occasional headaches
bound to TC Excessive vitamin B 12 in the circulation, e.g., such as after injections, usually exceeds the binding capacity of TC and is excreted in the urine
T., Cummings, C., and Gargus, J